BRIEF-Xencor's lead drug candidate receives orphan drug designation from FDA

* Xencor's lead drug candidate, xmab5871, receives orphan drug designation from fda for treatment of igg4-related disease Source text for Eikon: Further company coverage:

by reutersCOMPANYNEWS via Endless Supplies .Biz - News